Therapeutic agent delivery system and method

• US 4,715,850 A
• Filed: 12/06/1984
• Issued: 12/29/1987
• Est. Priority Date: 12/06/1984
• Status: Expired due to Fees

• Current Assignee: Loi Tran
• Original Assignee: Controlled Power Technologies Limited (Apollo Global Management, Inc.)
• Inventors: Tran, Loi H.
• Primary Examiner(s): Pellegrino, Stephen C.
• Application Number:
  US06/679,128
• Time in Patent Office: 1,118 Days
• Field of Search: 604/56, 604/65-67, 604/80-86, 604/114, 604/126, 604/245, 604/246, 604/890-892, 128/635, 417/48
• US Class Current: 604/82
• CPC Class Codes: A61M 5/1407 Infusion of two or more substances

Abstract

A method and apparatus for controllably administering a therapeutic agent to a patient is disclosed. The method and apparatus uses an electromotive force between an anode and a cathode to cause the therapeutic agent to migrate through a semipermeable membrane. The therapeutic agent is then delivered to the patient.

Claims

1. A therapeutic agent delivery system comprising:

housing means defining a cavity divided by a semipermeable membrane into a donor chamber of substantially constant volume adapted to hold the therapeutic agent and a receiving chamber adapted to receive the therapeutic agent from the donor chamber through the membrane;

an anode and a cathode in communication with the cavity with at least one of the anode and cathode being in communication with the donor chamber such that the therapeutic agent remains in the donor chamber until an electromotive force of a sufficient amount is applied between the anode and cathode whereby at least a portion of the therapeutic agent passes from the donor chamber to the receiving chamber; and

delivery means for delivering the therapeuric agent from the receiving chamber to a patient.

2. The therapeutic agent delivery system of claim 1 wherein the anode is in communication with the donor chamber and the cathode is in fluid communication with the receiving chamber.

3. The therapeutic agent delivery system of claim 1 wherein the anode and cathode are in communication with the donor chamber.

4. The therapeutic agent delivery system of claim 3 wherein the membrane is made of a hydrophobic material.

5. The therapeutic agent delivery system of claim 1 wherein the membrane is made of material which is permeable to cations but is substantially impermeable to anions.

6. The therapeutic agent delivery system of claim 5 wherein the membrane is made of an anionic polymer.

7. The therapeutic agent delivery system of claim 1 wherein the delivery means includes an outlet in fluid communication with the receiving chamber.

8. The therapeutic agent delivery system of claim 7 wherein the delivery means further includes an inlet in fluid communication with the receiving chamber such that a flow of liquid from the inlet to the outlet mixes with the therapeutic agent in the receiving chamber before delivery to the patient.

9. The therapeutic agent delivery system of claim 1 including power source means for generating the electromotive force.

10. The therapeutic agent delivery system of claim 9 including control means for controlling the electromotive force generated by power source means over time.

11. The therapeutic agent delivery system of claim 10 wherein the system is adapted for implantation in a living body.

12. The therapeutic agent delivery system of claim 1 wherein the donor chamber is defined within the receiving chamber.

13. The therapeutic agent delivery system of claim 1 wherein the receiving chamber is defined within the donor chamber.

14. The therapeutic agent delivery system of claim 1 including a therapeutic agent received in the donor chamber.

15. The therapeutic agent delivery system of claim 14 wherein the therapeutic agent is a drug.

16. A therapeutic agent delivery system comprising:

(a) a first housing defining a donor chamber adapted to hold the therapeutic agent;

(b) a second housing defining a receiving chamber adapted to receive the therapeutic agent;

(c) a semipermeable membrane in fluid contact with and separating the donor chamber and the receiving chamber, the membrane being of a material which is ion selective;

(d) a first electrode exposed within the donor chamber;

(e) a second electrode exposed within the receiving chamber such that the therapeutic agent remains in the donor chamber until an electromotive force of a sufficient amount is applied between the first and second electrodes and when the electromotive force is no longer applied between the electrode, no further therapeutic agent is delivered to the receiving chamber;

(f) an inlet on the second housing in fluid communication with the receiving chamber; and

(g) an outlet on the second housing in fluid communication with the receiving chamber.

17. The therapeutic agent delivery system of claim 16 wherein the semipermeable membrane is made of a material that is permeable to cations but is substantially impermeable to anions and the first electrode is an anode and the second electrode is a cathode.

18. The therapeutic agent delivery system of claim 17 wherein the membrane is made of an anionic polymer.

19. The therapeutic agent delivery system of claim 18 wherein the polymer is chosen from the group consisting of perfluorosulfonic acid polymers carboxylic acid polymers, and phosphoric acid polymers.

20. The therapeutic agent delivery system of claim 16 including power source means for generating the electromotive force.

21. The therapeutic agent delivery system of claim 20 including control means for controlling the electromotive force generated by power source means over time.

22. A method for controlling the administration of a therapeutic agent to a patient comprising the steps of:

(a) providing a housing having a semipermeable membrane defining a chamber and carrying an anode and cathode;

(b) maintaining the therapeutic agent in an ionic form in the chamber of substantially constant volume until an electromotive force is applied between the anode and cathode;

(c) applying an electromotive force between the anode and the cathode such that at least a portion of the agent migrates through the membrane; and

(d) delivering the agent which passes through the membrane to the patient.

23. The method of claim 22 wherein the anode and cathode are exposed within the chamber and the membrane is made of a hydrophobic material.

24. The method of claim 22 wherein the electromotive force changes the therapeutic agent from its ionized state to a neutral state.

25. The method of claim 22 wherein the membrane is made of an ion selective material and the anode and cathode are located on opposite sides of the membrane to generate a driving electromotive force across the membrane.

26. The method of claim 22 wherein the electromotive force varies over time.

27. The method of claim 22 wherein the agent passing through the membrane is delivered to the patient by a flow of a physiologically tolerable liquid.